Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms� pasture-raised promise is simple; its SEC filings are not. Whether you’re tracking how commodity feed prices hit egg margins or verifying the scale of its 300-plus family-farm network, each report holds critical details about this ethically minded food company. Stock Titan gathers every Vital Farms SEC filing in one place and layers in AI insights so you can grasp the story behind the numbers without wading through legal jargon.
Need the Vital Farms quarterly earnings report 10-Q filing? Curious about Vital Farms insider trading Form 4 transactions? Our platform delivers real-time EDGAR updates, then distills them into plain-English takeaways—revenue by product line, feed-cost sensitivity, sustainability KPIs, and more. You’ll see Vital Farms 8-K material events explained within minutes and receive concise summaries that point you straight to the line items that move the stock.
Investors use this page to:
- Monitor Vital Farms Form 4 insider transactions real-time and spot buying by executives before material announcements.
- Compare pasture-raised segment performance across periods with AI-annotated tables from each 10-Q.
- Dive into the Vital Farms annual report 10-K simplified to understand long-term supply-chain risks.
- Review the Vital Farms proxy statement executive compensation to see how pay aligns with ESG goals.
Every document�10-K, 10-Q, 8-K, Form 4, DEF 14A—is covered, refreshed instantly, and paired with machine-generated commentary. That means Vital Farms earnings report filing analysis and �understanding Vital Farms SEC documents with AI� are no longer separate tasks. Access comprehensive coverage, expert context, and actionable clarity on one dedicated page.
Vital Farms insider sale: Executive Chairperson and director Matthew Ohayer sold 800 shares on 08/19/2025 under a pre-established Rule 10b5-1 plan. The reported weighted-average sale price was $50.31, with individual trade prices ranging from $50.27 to $50.35. After the disposition the filing shows Mr. Ohayer directly beneficially owns 6,831,270 shares and is reported as the indirect beneficial owner of 716,000 shares held by his former spouse, over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 08/21/2025 and discloses the plan adoption date of March 14, 2025.
Kathryn McKeon, CMO and GM, Butter at Vital Farms (VITL), reported scheduled insider transactions in August 2025. On 08/15/2025 she sold 12,005 shares under a Rule 10b5-1 plan at a weighted average price of $47.59, reducing her beneficial holdings to 37,513 shares. On 08/18/2025 she exercised and acquired 21,442 shares under an employee stock option with a $15.31 exercise price and simultaneously sold 21,442 shares at a weighted average price of $49.08. After these transactions she beneficially owns 58,955 shares (direct). The Form 4 discloses the 10b5-1 plan was adopted on May 16, 2025, and the option vests in three equal annual installments starting 03/13/2024.
Vital Farms officer Joanne Bal reported the sale of 9,999 shares of the company's common stock on 08/15/2025 at a weighted average price of $47.70 per share, with transaction prices ranging from $47.60 to $47.81. After the sale, the reporting person beneficially owned 48,128 shares, a total that includes 229 shares acquired under the company's Employee Stock Purchase Plan on 05/15/2025. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing identifies the reporting person as an officer with the title GC, SEC. AND HEAD OF IMPACT.
Form 144 for Vital Farms, Inc. (VITL) shows a proposed sale of 21,442 common shares valued at $1,023,855.50 to be executed on 08/18/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing states these shares were acquired the same day by exercise of stock options from the issuer and paid in cash. The filer also reported recent 10b5-1 sales on 08/15/2025 of 12,005 shares generating $571,346.76. The filing includes an assurance that the signer does not possess undisclosed material adverse information.
Vital Farms insider sale by Director Denny Marie Post � On 08/14/2025 the reporting person sold 6,086 shares of Vital Farms, Inc. (VITL) common stock at a weighted average price of $47.75 per share. After the reported disposition the reporting person beneficially owned 16,312 shares. The filing notes the sale occurred in multiple transactions at prices ranging from $47.74 to $47.81 and that the signer, an attorney-in-fact, executed the Form 4 on behalf of the reporting person.
Vital Farms insider activity: Chief Financial Officer Thilo Wrede exercised employee stock options and sold common shares on 08/14/2025. The CFO exercised options with a $13.91 exercise price to acquire 7,189 shares, and reported ownership of 14,378 derivative shares following the transactions. On the same date, the Reporting Person sold 600 shares at a weighted average price of $47.06 and 2,793 shares at a weighted average price of $47.70 under a Rule 10b5-1 trading plan adopted May 15, 2025. Beneficial ownership reported after the transactions ranged from 62,176 to 58,783 common shares in the table entries.
Notice of proposed sale of 9,999 common shares by a person associated with Vital Farms, Inc. (VITL). The filing names Morgan Stanley Smith Barney LLC as the broker and lists an aggregate market value of $476,947.30 for the shares, against 44,685,980 shares outstanding. The planned approximate sale date is 08/15/2025. The shares were acquired through restricted stock vesting on 03/10/2024 (9,609 shares) and 04/26/2024 (390 shares). The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
The filing notifies a proposed sale of 12,005 shares of Vital Farms, Inc. common stock, with an aggregate market value of $573,238.75, to be sold on or about 08/15/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The shares were acquired as Restricted Stock Units on 03/22/2022 from the issuer. The filing reports 44,685,980 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. No additional remarks, trading plan date, or signatures are provided in the disclosed content.
Vital Farms, Inc. (VITL) Form 4: Director Karl Khoury reported the sale of 20,000 shares of Vital Farms common stock on 08/13/2025 at a weighted average price of $47.63 per share, with prices in the range $47.60 to $47.64. After the sale, Mr. Khoury beneficially owned 114,789 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025 and indicates the filing was submitted by a single reporting person. The filing discloses the weighted-average pricing and offers to provide details of the number of shares sold at each price within the stated range.
FAQ
What is the current stock price of Vital Farms (VITL)?
What is the market cap of Vital Farms (VITL)?
